CONSORT HEALTHCARE (BIRMINGHAM) LIMITED

• ⚠

  Material uncertainty over going concern

  However, these circumstances represent a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern in the later years of the project if the Noteholder does not provide further waivers (see note 1.2 to the financial statements).

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

• Turnover

  +8.3%

  £49,853,000 → £53,994,000

• Cash

  +10.8%

  £162,800,000 → £180,303,000

• Net assets

  +41.8%

  -£10,294,000 → -£5,986,000

• Employees

  —

  Not reported

• Operating profit

  +61.4%

  £3,065,000 → £4,946,000

• Profit before tax

  +125.5%

  -£22,549,000 → £5,744,000

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

KPMG LLP

Audit opinion

Unqualified (clean)

Going concern

Material uncertainty disclosed

“However, these circumstances represent a material uncertainty that may cast significant doubt on the Company's ability to continue as a going concern in the later years of the project if the Noteholder does not provide further waivers (see note 1.2 to the financial statements).”

Significant events

• “Consort Healthcare (Birmingham) Limited has entered into a Heads of Terms Agreement with BNHJV (the construction contractor) in relation to the passive fire protection matters, as a result the Company has agreed to contribute towards the cost of the misting solution and settlement agreement with BNHJV and the University Hospital Birmingham NHS Foundation Trust.”
• “Additionally, the Company entered into a Standstill Agreement with the University Hospital Birmingham NHS Foundation Trust (the Acute Trust), which expired on 1 April 2023. The Standstill Agreement was not extended, however, the Trust were clear that they did not want to pursue action against the Company.”
• “On 7 February 2024, the Company entered into Early Works Agreements with the Acute Trust and BNHJV, allowing works to commence in a singular ward to act as a pilot. The work to Ward 728 commenced on 11 April 2024 and completed on 2 December 2024.”
• “The Company entered into Early Works Agreements with the Acute Trust and BNHJV on 23 September 2024 for Ward 305 which commenced shortly after and is due to complete on 9 May 2025.”
• “On 24 September 2024, The Acute Trust and the Company signed a Remediation Framework Agreement which includes an open ended Standstill Agreement, which remains in place until the Settlement Variation Agreement (SVA) is signed or the parties agree to Terminate the agreement.”
• “The Company entered into a further Early Works Agreements with the Acute Trust and BNHJV for Ward 727 on 10 January 2025, this ward commenced on 13 January 2025 and is due to complete on 14 August 2025.”
• “On 26 June 2024, the Noteholder waived its entitlement to payment of subordinated debt interest between 1 May 2024 and 31 December 2024.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

1

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.